Use of a recombinant parvovirus to facilitate screening for human melanoma cell clones expressing tetracycline-responsive transactivators

Gene

Volumn 229, Issue 1-2, 1999, Pages 125-129

  Pacheco, Theresa R ^a   Maxwell, Françoise ^a   Wu, Ming Fang ^a,b   Na, Sopheap ^a   Maxwell, Ian H ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Melanoma; Parvovirus vector; Screening clones; Tetracycline regulation

Indexed keywords

DOXYCYCLINE; TETRACYCLINE;

ARTICLE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MOLECULAR CLONING; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION; VIRUS RECOMBINANT;

CLONE CELLS; DOXYCYCLINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MELANOMA; PARVOVIRUS; TETRACYCLINE; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSDUCTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033580385     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00034-7     Document Type: Article

References (12)

1. Diffoot N., Chen K.C., Bates R.C., Lederman M. The complete nucleotide sequence of parvovirus LuIII and localization of a unique sequence possibly responsible for its encapsidation pattern. Virology. 192:1993;339-345.
2. Furth P.A., St-Onge L., Boger H., Gruss P., Gossen M., Kistner A., Bujard H., Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA. 91:1994;9302-9306.
3. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:1992;5547-5551.
4. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1995;1766-1769.
5. Hofmann A., Nolan G.P., Blau H. M. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA. 93:1996;5185-5190.
6. Kistner A., Gossen M., Zimmerman F., Jerecic J., Ullmer C., Lubbert H., Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;0933-10938.
7. Maxwell I.H., Maxwell F. Electroporation of mammalian cells with a firefly luciferase expression plasmid: Kinetics of transient expression differ markedly among cell types. DNA. 7:1998;557-562.
8. Maxwell I.H., Maxwell F., Rhode S.L., Corsini J., Carlson J.O. Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells. Human Gene Therapy. 4:1993;441-450.
9. Maxwell I.H., Spitzer A.L., Long C.J., Maxwell F. Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters. Gene Therapy. 3:1996;28-36.
10. Resnitzky D., Gossen M., Bujard H., Reed S.I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1994;1669-1679.
11. Southern P.J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:1982;327-341.
12. Spitzer A.L., Maxwell F., Corsini J., Maxwell I.H. Species specificity for transduction of cultured cells by a recombinant LuIII rodent parvovirus genome encapsidated by canine parvovirus or feline panleukopenia virus. J. Gen. Virol. 77:1996;1787-1792.